Sue Leurgans

Last updated

Sue Ellen Leurgans is a biostatistician known for her work on disorders of human movement, including those caused by occupational injury and Parkinson's disease. She is a professor of neurological sciences at the Rush University Medical Center in Chicago. [1]

Leurgans graduated in statistics from Princeton University, [1] and earned her Ph.D. in statistics in 1978 from Stanford University. Her dissertation, Asymptotic Distribution Theory in Generalized Isotonic Regression, was supervised by Thomas W. Sager. [2] [3] She was a postdoctoral researcher at the University of Washington. [1] and is currently working on biostatistics. [4] [5] [6]

Leurgans is one of the authors of the 2007 revision of the Unified Parkinson's disease rating scale. [7] She was president of the Caucus for Women in Statistics in 1990. [8] She is married to physicist Cosmas Zachos.

Related Research Articles

Essential tremor Movement disorder that causes involuntary tremors

Essential tremor (ET), also called benign tremor, familial tremor, and idiopathic tremor, is a medical condition characterized by involuntary rhythmic contractions and relaxations of certain muscle groups in one or more body parts of unknown cause. It typically is symmetrical, and affects the arms, hands, or fingers; but sometimes involves the head, vocal cords, or other body parts. Essential tremor is either an action (intention) tremor—it intensifies when one tries to use the affected muscles during voluntary movements such as eating and writing—or it is a postural tremor, present with sustained muscle tone. This means that it is distinct from a resting tremor, such as that caused by Parkinson's disease, which is not correlated with movement.

Parkinsonism Medical condition

Parkinsonism is a clinical syndrome characterized by tremor, bradykinesia, rigidity, and postural instability. These are the four motor symptoms found in Parkinson's disease (PD), after which it is named, dementia with Lewy bodies (DLB), Parkinson's disease dementia (PDD), and many other conditions. A wide range of causes may lead to this set of symptoms, including neurodegenerative conditions, drugs, toxins, metabolic diseases, and neurological conditions other than PD.

Encephalitis lethargica Form of encephalitis (sleeping sickness)

Encephalitis lethargica is an atypical form of encephalitis. Also known as "sleeping sickness" or "sleepy sickness", it was first described in 1917 by the neurologist Constantin von Economo and the pathologist Jean-René Cruchet.

Cognitive pretesting, or cognitive interviewing, is a field research method where data is collected on how the subject answers interview questions. It is the evaluation of a test or questionnaire before it's administered. It allows survey researchers to collect feedback regarding survey responses and is used in evaluating whether the question is measuring the construct the researcher intends. The data collected is then used to adjust problematic questions in the questionnaire before fielding the survey to the full sample of people.

The Hoehn and Yahr scale is a commonly used system for describing how the symptoms of Parkinson's disease progress. It was originally published in 1967 in the journal Neurology by Margaret Hoehn and Melvin Yahr and included stages 1 through 5. Since then, a modified Hoehn and Yahr scale was proposed with the addition of stages 1.5 and 2.5 to help describe the intermediate course of the disease.

Management of Parkinson's disease due to the chronic nature of Parkinson's disease (PD), a broad-based program is needed that includes patient and family education, support-group services, general wellness maintenance, exercise, and nutrition. At present, no cure for the disease is known, but medications or surgery can provide relief from the symptoms.

Dihydroergocryptine

Dihydroergocryptine (DHEC), sold under the brand names Almirid and Cripar among others, is a dopamine agonist of the ergoline group that is used as an antiparkinson agent in the treatment of Parkinson's disease. It is taken by mouth.

The unified Parkinson's disease rating scale (UPDRS) is used to follow the longitudinal course of Parkinson's disease. The UPD rating scale is the most commonly used scale in the clinical study of Parkinson's disease.

Paratonia

Paratonia is the inability to relax muscles during muscle tone assessment. There are two types of paratonia: oppositional and facilitatory. Oppositional paratonia ("gegenhalten") occurs when subjects involuntarily resist to passive movements, while facilitatory paratonia ("mitgehen") occurs when subjects involuntary assist passive movements.

Ann Graybiel American neuroscientist

Ann Martin Graybiel is an Institute Professor and a faculty member in the Department of Brain and Cognitive Sciences at the Massachusetts Institute of Technology. She is also an investigator at the McGovern Institute for Brain Research. She is an expert on the basal ganglia and the neurophysiology of habit formation, implicit learning, and her work is relevant to Parkinson's disease, Huntington's disease, obsessive–compulsive disorder, substance abuse and other disorders that affect the basal ganglia.

Parkinsons disease Long-term degenerative neurological disorder

Parkinson's disease (PD), or simply Parkinson's, is a long-term degenerative disorder of the central nervous system that mainly affects the motor system. The symptoms usually emerge slowly, and as the disease worsens, non-motor symptoms become more common. The most obvious early symptoms are tremor, rigidity, slowness of movement, and difficulty with walking. Cognitive and behavioral problems may also occur with depression, anxiety, and apathy occurring in many people with PD. Parkinson's disease dementia becomes common in the advanced stages of the disease. Those with Parkinson's can also have problems with their sleep and sensory systems. The motor symptoms of the disease result from the death of cells in the substantia nigra, a region of the midbrain, leading to a dopamine deficit. The cause of this cell death is poorly understood, but involves the build-up of misfolded proteins into Lewy bodies in the neurons. Collectively, the main motor symptoms are also known as parkinsonism or a parkinsonian syndrome.

Anne B. Young American neuroscientist

Anne Buckingham Young is an American physician and neuroscientist who has made major contributions to the study of neurodegenerative diseases, with a focus on movement disorders like Huntington's disease and Parkinson's disease. Young completed her undergraduate studies at Vassar College and earned a dual MD/PhD from Johns Hopkins Medical School. She has held faculty positions at University of Michigan and Harvard University. She became the first female chief of service at Massachusetts General Hospital when she was appointed Chief of Neurology in 1991. She retired from this role and from clinical service in 2012. She is a member of many academic societies and has won numerous awards. Young is also the only person to have been president of both the international Society for Neuroscience and the American Neurological Association.

Lee Silverman voice treatment

The Lee Silverman Voice Treatment – LOUD is a treatment for speech disorders associated with Parkinson's disease (PD). It focuses on increasing vocal loudness and is delivered by a speech therapist in sixteen one-hour sessions spread over four weeks. A derivative of this treatment, known as LSVT BIG, is used in treating movement aspects of Parkinson's disease.

Joseph Jankovic American neurologist

Joseph Jankovic, M.D., Professor of Neurology, Distinguished Chair in Movement Disorders, and Founder and Director of the Parkinson's Disease Center and Movement Disorders Clinic, is an American neurologist at Baylor College of Medicine in Houston, Texas. Jankovic has served as the principal investigator in hundreds of clinical trials and his pioneering research in etiology, pathogenesis, and classification of various movement disorders and on experimental therapeutics. Jankovic has contributed to classifications, characterization, and therapeutic guidelines of various movement disorders. He has served as the principal investigator in hundreds of clinical trials and his research on drugs for parkinsonian disorders and hyperkinetic movement disorders, including botulinum toxin (Botox) and tetrabenazine, has led to their approval by the United States Food and Drug Administration.

The REM Sleep Behavior Disorder Screening Questionnaire (RBDSQ) is a specific questionnaire for rapid eye movement behavior disorder (RBD) developed by Stiasny-Kolster and team, to assess the most prominent clinical features of RBD. It is a 10-item, patient self-rating instrument with short questions to be answered by either 'yes' or 'no'. The validity of the questionnaire was studied by researchers and they have observed it to perform with high sensitivity and reasonable specificity in the diagnosis of RBD.

Edna Schechtman is an Israeli statistician, a professor emeritus of statistics at the Department of Industrial Engineering and Management, Ben-Gurion University of the Negev. She is best known for development of statistical tools that utilize the Gini Mean Difference (GMD) as the measure of association.

Paula Karen Roberson is a biostatistician at the University of Arkansas for Medical Sciences, where she chairs the department of biostatistics. Her research interests include the design of clinical trials, nonparametric statistics, and feature selection. She was president of the Caucus for Women in Statistics in 2015.

Erika F. Augustine is an Associate Professor of Neurology and Pediatrics at the University of Rochester Medical Center in Rochester, New York. Augustine co-directs the University of Rochester Batten Center, and is the Associate Director of both the Center for Health and Technology and the Udall Center of Excellence in Parkinson’s Disease Research. Augustine’s clinical research and medical practice specialize in pediatric movement disorders. She leads clinical trials for Batten diseases, a group of rare pediatric neurodegenerative disorders, and she has developed a novel telemedicine model to increase the efficacy of remote care for patients with rare diseases.

Mel B. Feany is an American neuropathologist and geneticist at Brigham and Women's Hospital who researches neurodegenerative disease. She has been a co-editor of the Annual Review of Pathology: Mechanisms of Disease since 2017.

Cyntha Anne Struthers is a Canadian mathematical statistician whose research topics include missing data in longitudinal studies and proportional hazards models. She is an associate professor of statistics and actuarial science at the University of Waterloo, and the former president of the Caucus for Women in Statistics.

References

  1. 1 2 3 Sue E. Leurgans, PhD, Michael J. Fox Foundation for Parkinson's Research, retrieved 2019-01-19
  2. Sue Leurgans at the Mathematics Genealogy Project
  3. Leurgans, S. (1982). "Asymptotic distributions of slope-of-greatest-convex-minorant estimators", The Annals of Statistics, 10 pp 287-296,online
  4. PubMed database list of SE Leurgans' biomedical publications
  5. MyBibliography publications
  6. Publications in Google Scholar
  7. Goetz, Christopher G.; Fahn, Stanley; Martinez-Martin, Pablo; Poewe, Werner; Sampaio, Cristina; Stebbins, Glenn T.; Stern, Matthew B.; Tilley, Barbara C.; Dodel, Richard; Dubois, Bruno; Holloway, Robert; Jankovic, Joseph; Kulisevsky, Jaime; Lang, Anthony E.; Lees, Andrew; Leurgans, Sue; LeWitt, Peter A.; Nyenhuis, David; Olanow, C. Warren; Rascol, Olivier; Schrag, Anette; Teresi, Jeanne A.; Van Hilten, Jacobus J.; LaPelle, Nancy (1 January 2007), "Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan", Movement Disorders, 22 (1): 41–47, doi: 10.1002/mds.21198 , PMID   17115387
  8. Presidents 1971–2017 (PDF), Caucus for Women in Statistics , retrieved 2019-01-19